MARUCCI, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.881
EU - Europa 8.946
AS - Asia 6.500
SA - Sud America 815
AF - Africa 254
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 16
Totale 34.484
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.346
CN - Cina 2.624
SG - Singapore 1.888
RU - Federazione Russa 1.850
PL - Polonia 1.548
IT - Italia 1.387
DE - Germania 1.131
BR - Brasile 669
GB - Regno Unito 626
FR - Francia 564
HK - Hong Kong 521
UA - Ucraina 507
SE - Svezia 503
VN - Vietnam 495
CA - Canada 451
FI - Finlandia 351
TR - Turchia 242
KR - Corea 211
ZA - Sudafrica 171
IE - Irlanda 127
IN - India 121
JP - Giappone 98
BE - Belgio 80
EU - Europa 71
AR - Argentina 65
MX - Messico 62
NL - Olanda 59
BD - Bangladesh 42
CZ - Repubblica Ceca 41
IR - Iran 38
ES - Italia 36
PK - Pakistan 30
IQ - Iraq 29
EC - Ecuador 23
RO - Romania 23
AT - Austria 22
AE - Emirati Arabi Uniti 18
TW - Taiwan 18
ID - Indonesia 16
KE - Kenya 15
CH - Svizzera 14
CO - Colombia 14
EG - Egitto 14
MA - Marocco 14
RS - Serbia 13
JO - Giordania 12
LT - Lituania 12
PE - Perù 12
SA - Arabia Saudita 12
AU - Australia 11
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
VE - Venezuela 11
AZ - Azerbaigian 10
IL - Israele 10
LB - Libano 7
PH - Filippine 7
BG - Bulgaria 6
CI - Costa d'Avorio 6
HR - Croazia 6
OM - Oman 6
AM - Armenia 5
BY - Bielorussia 5
CL - Cile 5
DZ - Algeria 5
GR - Grecia 5
MY - Malesia 5
AL - Albania 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
NO - Norvegia 4
NP - Nepal 4
ET - Etiopia 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BO - Bolivia 2
CR - Costa Rica 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
LY - Libia 2
MU - Mauritius 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AS - Samoa Americane 1
BA - Bosnia-Erzegovina 1
Totale 34.463
Salva come PNG Salva come JPEG
Città #
Fairfield 1.492
Woodbridge 1.482
Ashburn 1.380
Dallas 1.320
Jacksonville 1.207
Warsaw 1.198
Singapore 980
Chandler 948
Houston 815
San Jose 765
Ann Arbor 709
Wilmington 687
Seattle 637
Cambridge 543
Boardman 510
Hong Kong 490
Beijing 425
Nanjing 409
Kraków 331
Toronto 294
Los Angeles 266
The Dalles 264
Camerino 237
Istanbul 191
Columbus 186
San Mateo 185
Seoul 182
Düsseldorf 178
Helsinki 172
Tongling 167
Lawrence 163
Princeton 163
Dearborn 158
Ho Chi Minh City 158
New York 157
Johannesburg 154
Lauterbourg 144
Ogden 136
Moscow 133
London 126
Dublin 125
Nanchang 125
Buffalo 117
Lachine 117
Council Bluffs 111
Shanghai 109
Munich 105
Milan 101
Hanoi 100
Guangzhou 99
Chicago 88
Kunming 86
Santa Clara 83
Tokyo 82
Brussels 75
San Diego 75
São Paulo 75
Shenyang 67
Tianjin 64
Frankfurt am Main 63
Jiaxing 62
Hebei 61
Orem 58
Hangzhou 45
Edinburgh 44
Wuhan 39
Denver 38
Centro 37
Philadelphia 37
Venezia 36
Changsha 35
Chennai 35
Ningbo 35
Rome 34
Dong Ket 31
Hefei 31
Redwood City 30
Poplar 29
Stockholm 29
Turku 29
Brno 28
Brooklyn 28
Phoenix 28
Jinan 27
Manchester 27
San Francisco 27
Boston 26
Da Nang 26
Trieste 26
Venice 26
Orange 25
Norwalk 24
Perugia 24
Amsterdam 23
Atlanta 23
Falls Church 23
Bremen 22
Hillsboro 22
Yiwu 22
Haiphong 21
Totale 23.282
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 606
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 587
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 544
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 526
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 521
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 437
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 402
Overview on Radiolabel-Free in Vitro Assays for GPCRs 397
Pharmacological characterization of the GPR17 receptor dual profile 379
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 376
GPR17 receptor modulators and their therapeutic implications: review of recent patents 373
The G Protein-Coupled Receptor GPR17: Overview and Update 366
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 358
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 348
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 304
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 290
“Synthesis and α-Adrenoreceptor Blocking Properties of Phenoxybenzamine-Related (2-Chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) Amines”. 284
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 283
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 280
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 274
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 271
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 267
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 265
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 263
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 263
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 259
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 255
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 247
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 244
“New Pyridazinones: Synthesis and Correlation Between Structure and α-Blocking Activity”. 242
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 241
5HT2B receptor antagonists: a probe for spotting the pharmacophore 240
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 234
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 234
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 234
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 233
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 230
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 227
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 226
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 226
"[4-[[N-(3-Chlorophenyl)carbamoyl]-2-butynyl]-trimethylammonium (McN-A-343)-Related Compounds. Effect of the Butynyl Chain Inclusion into an Aromatic Unit of the Potency for Muscarinic Receptors 225
New sensible method to quantize the intestinal absorption of receptor ligands 222
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 221
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 220
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 220
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 220
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 219
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 219
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 218
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 216
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 216
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 214
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 214
Antiviral properties of deazaadenine nucleoside derivatives 214
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 212
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 212
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 211
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 211
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 210
Analogues of Prazosin That Bear a Benextramine-Related Polyamine Backbone Exhibit Different Antagonism toward alpha1-Adrenoceptor Subtypes 210
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 209
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 208
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 208
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 207
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 206
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 206
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 204
Adenosine receptor modeling: what does the A2A crystal structure tell us? 203
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 203
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 202
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 202
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 201
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 199
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 198
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 198
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 198
Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines 196
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 196
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 196
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 194
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 193
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 193
Synthesis and α1-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone 193
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 191
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 190
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 189
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 188
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 187
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 187
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 187
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 184
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 184
“Synthesis and α1-Antagonist Activity of New Prazosin-and Benextramine-Related Tetraamine Disulfides”. 184
“Synthesis and Pharmacological Activity of Some New Pyridazinones”. 183
Synthesis and pharmacological characterization of new chiral derivatives of muscarine and allo-muscarine 181
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 181
3-arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands 180
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 180
Structure-Activity Relationships of Methoctramine-Related Polyamines as Muscular Nicotinic Receptor Noncompetitive Antagonists. 2. Role of Polymethylene Chain Lengths Separating Amine Functions and of Substituents on the Terminal Nitrogen Atoms. 180
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 179
Totale 24.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.100 0 0 0 0 0 0 0 0 0 188 556 356
2021/20221.977 189 478 39 103 99 65 100 154 145 228 147 230
2022/20232.322 257 120 84 384 260 312 13 146 385 121 170 70
2023/20241.769 252 102 112 59 71 115 86 103 198 70 63 538
2024/20255.716 203 146 485 264 159 340 639 1.449 429 403 399 800
2025/20268.446 534 593 1.706 1.137 959 660 1.363 583 546 365 0 0
Totale 34.984